Succinylcholine Chloride Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 20 mg/mL, 100 mg/mL
Reference Brands: Anectine (USA), Quelicin (USA)
Category:
Anaesthetics
Succinylcholine Chloride is available in Injection
and strengths such as 20 mg/mL, 100 mg/mL.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Succinylcholine Chloride is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Succinylcholine Chloride can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Succinylcholine Chloride is the chloride salt form of succinylcholine, a quaternary ammonium compound that functions as a rapid-acting depolarizing neuromuscular blocking agent. It is primarily used to induce short-term skeletal muscle relaxation during general anesthesia, rapid sequence intubation, and certain emergency or surgical procedures where quick onset and brief duration of action are essential. Structurally similar to acetylcholine, Succinylcholine Chloride binds to nicotinic acetylcholine receptors at the neuromuscular junction and opens ligand-gated ion channels, leading to depolarization of the motor end plate.
Unlike acetylcholine, succinylcholine is resistant to breakdown by acetylcholinesterase at the synaptic cleft, resulting in prolonged depolarization. This sustained depolarized state prevents further neuromuscular transmission, initially causing transient muscle fasciculations followed by skeletal muscle relaxation and flaccid paralysis. The drug’s effects are short-lived due to rapid hydrolysis by plasma pseudocholinesterase, allowing for quick recovery of muscle function.
Because Succinylcholine Chloride causes complete muscle paralysis, it must be administered only in controlled medical environments with adequate airway management and ventilatory support. Its predictable onset and brief duration make it especially valuable in anesthesia and emergency medicine when rapid, temporary neuromuscular blockade is required.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing